Wnt signaling pathway is involved in the pathogenesis of amyotrophic lateral sclerosis in adult transgenic mice

References

• Gordon PH. Advances in clinical trials for amyotrophic lateral sclerosis. Curr Neurol Neurosci Rep. 2005;5:48–54.
   PubMedGoogle Scholar
• Lepore AC, O’Donnell J, Kim AS, Williams T, Tuteja A, Rao MS, et al.. Human glial-restricted progenitor transplantation into cervical spinal cord of the SOD1 mouse model of ALS. PLoS One. 2011;6:e25968.
   PubMed Web of Science ®Google Scholar
• Banack SA, Caller TA, Stommel EW. The cyanobacteria derived toxin Beta-N-methylamino-L-alanine and amyotrophic lateral sclerosis. Toxins (Basel). 2010;2:2837–50.
   PubMed Web of Science ®Google Scholar
• Liang H, Ward WF, Jang YC, Bhattacharya A, Bokov AF, Li Y, et al.. PGC-1α protects neurons and alters disease progression in an amyotrophic lateral sclerosis mouse model. Muscle Nerve. 2011;44:947–56.
   PubMed Web of Science ®Google Scholar
• Gurney ME, Pu H, Chiu AY, Dal Canto MC, Polchow CY, Alexander DD, et al.. Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation. Science. 1994;264:1772–5.
   PubMed Web of Science ®Google Scholar
• Liu R, Althaus JS, Ellerbrock BR, Becker DA, Gurney ME. Enhanced oxygen radical production in a transgenic mouse model of familial amyotrophic lateral sclerosis. Ann Neurol. 1998;44:763–70.
   PubMed Web of Science ®Google Scholar
• Boillée S, Velde VandeC, Cleveland DW. ALS: a disease of motor neurons and their nonneuronal neighbors. Neuron. 2006;52:39–59.
   PubMed Web of Science ®Google Scholar
• Ferraiuolo L, Kirby J, Grierson AJ, Sendtner M, Shaw PJ. Molecular pathways of motor neuron injury in amyotrophic lateral sclerosis. Nat Rev Neurol. 2011;7:616–30.
   PubMed Web of Science ®Google Scholar
• Ludolph AC, Jesse S. Evidence-based drug treatment in amyotrophic lateral sclerosis and upcoming clinical trials. Ther Adv Neurol Disord. 2009;2:319–26.
   PubMedGoogle Scholar
• Moon RT, Bowerman B, Boutros M, Perrimon N. The promise and perils of Wnt signaling through beta-catenin. Science. 2002;296:1644–6.
   PubMed Web of Science ®Google Scholar
• Moon RT, Kohn AD, Ferrari DeGV, Kaykas A. WNT and beta-catenin signalling: diseases and therapies. Nat Rev Genet. 2004;5:691–701.
   PubMed Web of Science ®Google Scholar
• Zhang L, Yang X, Yang S, Zhang J. The Wnt/β-catenin signaling pathway in the adult neurogenesis. Eur J Neurosci. 2011;33:1–8.
   PubMed Web of Science ®Google Scholar
• Gordon MD, Nusse R. Wnt signaling: multiple pathways, multiple receptors, and multiple transcription factors. J Biol Chem. 2006;281:22429–33.
   PubMed Web of Science ®Google Scholar
• Caricasole A, Copani A, Caraci F, Aronica E, Rozemuller AJ, Caruso A, et al.. Induction of Dickkopf-1, a negative modulator of the Wnt pathway, is associated with neuronal degeneration in Alzheimer’s brain. J Neurosci. 2004;24:6021–7.
   PubMed Web of Science ®Google Scholar
• Silva da Cruz eOA, Henriques AG, Domingues SC, Silva da Cruz eEF. Wnt signalling is a relevant pathway contributing to amyloid beta- peptide-mediated neuropathology in Alzheimer’s disease. CNS Neurol Disord Drug Targets. 2010;9:720–6.
   PubMed Web of Science ®Google Scholar
• Godin JD, Poizat G, Hickey MA, Maschat F, Humbert S. Mutant huntingtin-impaired degradation of beta-catenin causes neurotoxicity in Huntington’s disease. EMBO J. 2010;29:2433–45.
   PubMed Web of Science ®Google Scholar
• Guan YJ, Wang X, Wang HY, Kawagishi K, Ryu H, Huo CF, et al.. Increased stem cell proliferation in the spinal cord of adult amyotrophic lateral sclerosis transgenic mice. J Neurochem. 2007;102:1125–38.
   PubMed Web of Science ®Google Scholar
• Mead RJ, Bennett EJ, Kennerley AJ, Sharp P, Sunyach C, Kasher P, et al.. Optimised and rapid pre-clinical screening in the SOD1(G93A) transgenic mouse model of amyotrophic lateral sclerosis (ALS). PLoS One. 2011;6:e23244.
   PubMedGoogle Scholar
• Chiu AY, Zhai P, Canto DalMC, Peters TM, Kwon YW, Prattis SM, et al.. Age-dependent penetrance of disease in a transgenic mouse model of familial amyotrophic lateral sclerosis. Mol Cell Neurosci. 1995;6:349–62.
   PubMed Web of Science ®Google Scholar
• Vargas MR, Johnson DA, Sirkis DW, Messing A, Johnson JA. Nrf2 activation in astrocytes protects against neurodegeneration in mouse models of familial amyotrophic lateral sclerosis. J Neurosci. 2008;28:13574–81.
   PubMed Web of Science ®Google Scholar
• Sousa KM, Villaescusa JC, Cajanek L, Ondr JK, Castelo-Branco G, Hofstra W, et al.. Wnt2 regulates progenitor proliferation in the developing ventral midbrain. J Biol Chem. 2010;285:7246–53.
   PubMed Web of Science ®Google Scholar
• Wang HX, Li TY, Kidder GM. WNT2 regulates DNA synthesis in mouse granulosa cells through beta-catenin. Biol Reprod. 2010;82:865–75.
   PubMed Web of Science ®Google Scholar
• Nakatsu MN, Ding Z, Ng MY, Truong TT, Yu F, Deng SX. Wnt/β-catenin signaling regulates proliferation of human cornea epithelial stem/progenitor cells. Invest Ophthalmol Vis Sci. 2011;52:4734–41.
   PubMed Web of Science ®Google Scholar
• Qu Q, Sun G, Li W, Yang S, Ye P, Zhao C, et al.. Orphan nuclear receptor TLX activates Wnt/beta-catenin signalling to stimulate neural stem cell proliferation and self-renewal. Nat Cell Biol. 2010;12:31–40.
   PubMed Web of Science ®Google Scholar
• Doble BW, Woodgett JR. Role of glycogen synthase kinase-3 in cell fate and epithelial-mesenchymal transitions. Cells Tissues Organs. 2007;185:73–84.
   PubMed Web of Science ®Google Scholar
• Stambolic V, Woodgett JR. Mitogen inactivation of glycogen synthase kinase-3 in intact cells via serine 9 phosphorylation. Biochem J. 1994;303:701–4.
   PubMed Web of Science ®Google Scholar
• Leroy K, Brion JP. Developmental expression and localization of glycogen synthase kinase-3 beta in rat brain. J Chem Neuroanat. 1999;16:279–93.
   PubMed Web of Science ®Google Scholar
• Stambolic V, Ruel L, Woodgett JR. Lithium inhibits glycogen synthase kinase-3 activity and mimics wingless signalling in intact cells. Curr Biol. 1996;6:1664–8.
   PubMed Web of Science ®Google Scholar
• Toledo EM, Colombres M, Inestrosa NC. Wnt signaling in neuroprotection and stem cell differentiation. Prog Neurobiol. 2008;86:281–96.
   PubMed Web of Science ®Google Scholar
• Sofola O, Kerr F, Rogers I, Killick R, Augustin H, Gandy C, et al.. Inhibition of GSK-3 ameliorates Abeta pathology in an adult-onset Drosophila model of Alzheimer’s disease. PLoS Genet. 2010;6:e1001087.
   PubMed Web of Science ®Google Scholar